11 found
Order:
  1.  20
    Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies.Oliver Feeney, Julian Cockbain, Michael Morrison, Lisa Diependaele, Kristof Van Assche & Sigrid Sterckx - 2018 - American Journal of Bioethics 18 (12):36-48.
    In 2012, a new and promising gene manipulation technique, CRISPR-Cas9, was announced that seems likely to be a foundational technique in health care and agriculture. However, patents have been granted. As with other technological developments, there are concerns of social justice regarding inequalities in access. Given the technologies’ “foundational” nature and societal impact, it is vital for such concerns to be translated into workable recommendations for policymakers and legislators. Colin Farrelly has proposed a moral justification for the use of patents (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   11 citations  
  2.  77
    Equality of Whom? A Genetic Perspective on Equality (of Opportunity).Oliver Feeney - 2006 - Res Publica 12 (4):357-383.
    Rawls’ principle of fair equality of opportunity has been regularly discussed and criticized for being inadequate regarding natural inequalities. In so far as this egalitarian goal is sound, the purpose of the paper is to see how the prospect of radical genetic intervention might affect this particular inadequacy. I propose that, in a post-genetic setting, an appropriate response would be to extend the same rules regulating societal inequalities to a regulation of comparable genetic inequalities. I defend this stance against recent (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  3.  8
    Commentary: Enlightened Democracy in Practice.Oliver Feeney - 2019 - Cambridge Quarterly of Healthcare Ethics 28 (1):89-92.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  4.  6
    European Electronic Personal Health Records Initiatives and Vulnerable Migrants: A Need for Greater Ethical, Legal and Social Safeguards.Oliver Feeney, Gabriele Werner‐Felmayer, Helena Siipi, Markus Frischhut, Silvia Zullo, Ursela Barteczko, Lars Øystein Ursin, Shai Linn, Heike Felzmann, Dušanka Krajnović, John Saunders & Vojin Rakić - 2020 - Developing World Bioethics 20 (1):27-37.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  5.  5
    Editing the Gene Editing Debate: Reassessing the Normative Discussions on Emerging Genetic Technologies.Oliver Feeney - 2019 - NanoEthics 13 (3):233-243.
    The revolutionary potential of the CRISPR-Cas9 gene editing technique has created a resurgence in enthusiasm and concern in genetic research perhaps not seen since the mapping of the human genome at the turn of the century. Some such concerns and anxieties revolve around crossing lines between somatic and germline interventions as well as treatment and enhancement applications. Underpinning these concerns, there are familiar concepts of safety, unintended consequences and damage to genetic identity and the creation of designer children through pursuing (...)
    Direct download (2 more)  
    Translate
     
     
    Export citation  
     
    Bookmark  
  6.  38
    Germ-Line Enhancements, Inequalities and the Egalitarian Ethos.Oliver Feeney - 2010 - Law and Ethics of Human Rights 4 (2).
    In most discussions of the social justice implications of new genetic technologies, enhancements are considered to be highly contentious. This is particularly so when we speak of enhancements that benefit the recipient in positional terms and enhancements that are germ-line and which can be passed on to future generations. I argue that the egalitarian reluctance, as displayed by Max Mehlman, to permitting enhancements is overblown. Recent writings from Buchanan and Farrelly highlight a more positive, context-dependent, role for permitting the socio-economically (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  7. Incentives, Genetics and the Egalitarian Ethos.Oliver Feeney - 2012 - Ethical Perspectives 19 (1):83-102.
    Given the constraints of human partiality and the possible social benefits of widespread genetic technology, allowing for incentive-based inequalities in access in order to boost innovation and diffusion may be the only feasible option available to the post-genomics egalitarian planner. In light of the prevailing ethos that exists in the non-ideal circumstances of society, an initial post-genomics egalitarian goal for all to have equivalent access to comparable genetic interventions seems very unlikely to succeed.While I outline how the initial egalitarian goal (...)
     
    Export citation  
     
    Bookmark   1 citation  
  8.  44
    Parental Planning and New Reproductive Technologies: Wilkinson, Stephen. 2010. Choosing Tomorrow’s Children: The Ethics of Selective Reproduction. Oxford: Clarendon Press, 265 Pp.Oliver Feeney - 2011 - Res Publica 17 (3):303-309.
  9.  8
    Regulating Germline Editing in Assisted Reproductive Technology: An EU Cross‐Disciplinary Perspective.Ana Nordberg, Timo Minssen, Oliver Feeney, Iñigo Miguel Beriain, Lucia Galvagni & Kirmo Wartiovaara - 2020 - Bioethics 34 (1):16-32.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  10.  10
    Regulating Germline Editing in Assisted Reproductive Technology: An EU Cross‐Disciplinary Perspective.Ana Nordberg, Timo Minssen, Oliver Feeney, Iñigo de Miguel Beriain, Lucia Galvagni & Kirmo Wartiovaara - 2020 - Bioethics 34 (1):16-32.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  11.  20
    Response to Open Peer Commentaries on “Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies”.Sigrid Sterckx, Kristof Van Assche, Lisa Diependaele, Michael Morrison, Julian Cockbain & Oliver Feeney - 2019 - American Journal of Bioethics 19 (1):W10-W13.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark